You are here: Industry Insights > Roche

News List

Roche confident of closing Spark Therapeutics purchase despite facing offer extension, delay to antitrust review firstwordpharma
April 04, 2019
A Roche spokesman said Wednesday that the company remains confident that the purchase of Spark Therapeutics will be completed by the end of June, despite having to extend the offer period after only 29.4 percent of shares were tendered.
MacroGenics Nabs $380M Pact With Drug Giant Roche biospace
January 05, 2018
MacroGenics Enters Research Collaboration with Roche to Develop a Novel Bispecific Molecule
FDA grants breast cancer approval to Roche's Perjeta/Herceptin combo therapy pharmafile
December 22, 2017
Roche has announced that the FDA has granted approval to Perjeta in combination with Herceptin and a Perjeta-based) chemotherapy regimen for the adjuvant treatment of HER2-positive early breast cancer which is at a high chance of recurrence.
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer fiercepharma
November 08, 2017
Roche's lung cancer drug Alecensa had been relegated to patients who'd failed on treatment with one of its rivals, but a new FDA nod is changing all that.
EU green light for Roche’s Tecentriq pharmatimes
September 26, 2017
Roche has received European Commission approval for its anti-PD-L1 cancer immunotherapy Tecentriq (atezolizumab) to treat specific lung and bladder cancers.
Samsung wins first CHMP backing for a Herceptin biosim, imperiling $2B in Roche sales fiercepharma
September 18, 2017
As challengers to Roche’s cancer blockbusters advance in the U.S. and around the world, Samsung Bioepis has taken a big step toward approval for a Herceptin biosim in Europe.
Shire injunction blocks Roche’s ‘misleading’ statements on haemophilia drugs pharmaphorum
July 11, 2017
Shire has taken out an injunction limiting how Roche can talk about its haemophilia drug, as the two companies fight for a share of this $11 billion market.